Takeda Pharmaceutical Li... (TAK)

AI Score

Unlock

14.77

-0.28 (-1.86%)

At close: Mar 31, 2025, 10:36 AM

Takeda Pharmaceutical Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00
Cash & Equivalents	457.8B	533.53B	849.7B	966.22B	637.61B	702.09B	294.52B	319.45B	451.43B	652.15B	666.05B	289.61B	454.25B	217.9B	266.54B	229.53B	1,613.2B	1,647.7B	1,626.2B	1,264.3B	1,076.1B	1,023B	753.32B	634.38B
Short-Term Investments	15.09B	20.17B	25.3B	36.6B	15.82B	23.28B	80.65B	56.68B	108.6B	61.27B	184.98B	258.09B	1.38B	656.32B	616.68B	529.25B	71.75B	152.24B	243.28B	257.8B	241.67B	118.43B	187.89B	89.06B
Long-Term Investments	430.61B	378.86B	330.13B	348.35B	369.45B	306.9B	304.38B	303.05B	159.56B	251.75B	202.81B	-81.39B	185.32B	-491.3B	-418.83B	-340.12B	221.02B	242.4B	144.68B	46.05B	114.92B	175.05B	218.85B	299.41B
Other Long-Term Assets	51.21B	63.33B	82.61B	100.34B	103.85B	87.47B	77.98B	54.41B	45.6B	82.41B	72.86B	359.84B	128.82B	739.99B	703.79B	607.36B	72.18B	63.12B	54.08B	39B	13.12B	14.74B	-5.28B	-5.09B
Receivables	697.61B	681.69B	724.38B	812.71B	784.92B	749.12B	428.79B	444.78B	430.57B	466.83B	442.66B	342.37B	341.82B	293.1B	279.7B	301.45B	n/a	n/a	n/a	225.14B	290.52B	264.69B	290.5B	301.25B
Inventory	1,209.9B	986.46B	853.17B	753.88B	759.6B	986.74B	212.94B	226.29B	254.01B	262.35B	254.33B	229.53B	195.01B	137.13B	137.7B	131.66B	116.13B	105.31B	98.26B	94.56B	92.93B	89.48B	96.09B	100.42B
Other Current Assets	193.3B	196.28B	166.4B	180.08B	287.3B	622.15B	61.9B	213.45B	129.18B	77.47B	44.51B	335.48B	286.53B	281.8B	272.26B	283.7B	195.38B	191.03B	180.82B	128.09B	28.95B	46.64B	17.3B	13.85B
Total Current Assets	2,558.6B	2,398B	2,593.6B	2,712.9B	2,469.4B	3,050.7B	1,078.8B	1,260.7B	1,373.8B	1,520.1B	1,592.5B	1,455.1B	1,279B	1,586.3B	1,572.9B	1,475.6B	2,243.8B	2,357.7B	2,372B	1,969.9B	1,730.1B	1,542.2B	1,345.1B	1,139B
Property-Plant & Equipment	1,989.8B	1,691.2B	1,582.8B	1,453.9B	1,386.4B	1,316.5B	536.8B	530.15B	551.92B	526.16B	542.25B	511.1B	488.7B	407.48B	318.95B	258.49B	236.13B	238.45B	215.67B	220.13B	230.54B	203.28B	213.38B	220.36B
Goodwill & Intangibles	9,684.7B	9,060.4B	8,226.3B	7,943B	8,183.9B	9,021.8B	2,043.5B	2,088.5B	1,522.4B	1,761.3B	1,950.3B	1,689.7B	1,475B	517.43B	639.89B	747.75B	71.75B	152.24B	243.28B	257.8B	241.67B	118.43B	187.89B	89.06B
Total Long-Term Assets	12,550.2B	11,559.8B	10,584.4B	10,199.4B	10,351.7B	10,821.7B	3,027.7B	3,095.1B	2,450.3B	2,776.1B	2,976.6B	2,500.5B	2,298B	1,200.2B	1,250.4B	1,284.6B	605.49B	714.79B	670.32B	575.52B	605.51B	517.17B	620.12B	608.82B
Total Assets	15,108.8B	13,957.8B	13,178B	12,912.3B	12,821.1B	13,872.3B	4,106.5B	4,355.8B	3,824.1B	4,296.2B	4,569.1B	3,955.6B	3,577B	2,786.4B	2,823.3B	2,760.2B	2,849.3B	3,072.5B	3,042.3B	2,545.4B	2,335.7B	2,059.4B	1,965.2B	1,747.8B
Account Payables	319.95B	307.45B	295.93B	232.1B	211.63B	212.35B	133.71B	54.88B	92.07B	83.29B	129.34B	169.87B	91.69B	80.32B	195.91B	238.8B	72.47B	55.19B	50.72B	45.73B	52.64B	54.41B	56.95B	91.08B
Deferred Revenue	n/a	740.74B	644.42B	616.48B	587.98B	627.26B	200.47B	206.38B	158.47B	459.66B	177.68B	441.84B	243.89B	208.97B	213.1B	208.69B	267.66B	273.15B	342.82B	240.6B	232.26B	214.32B	203.16B	195.92B
Short-Term Debt	367.25B	399.22B	257.87B	72.34B	627.9B	987.09B	2.15B	547.14B	231.82B	103.25B	158.28B	4.5B	244.7B	4.13B	3.29B	3.21B	3.36B	9.57B	9.11B	12.94B	9.98B	7.69B	10.14B	9.45B
Other Current Liabilities	1,516B	1,542.9B	1,391B	1,323.5B	1,153.6B	1,234.1B	533.97B	693.75B	490.18B	789.21B	110.66B	325.83B	391.24B	310.17B	180.41B	159.32B	262.62B	276.92B	276.45B	226.03B	214.09B	198.31B	221.93B	167.73B
Total Current Liabilities	2,313.1B	2,481.9B	2,145.7B	1,773.2B	2,175.9B	2,510.9B	737.51B	1,366.1B	857.21B	1,016.8B	802.75B	613.63B	751.73B	436.6B	428.48B	472.11B	428.71B	442.41B	488.23B	365.5B	370.56B	344.7B	371.79B	345.63B
Long-Term Debt	5,029.9B	4,462.5B	4,552.8B	4,999.4B	4,834.9B	4,943.3B	1,036.7B	656.56B	590.38B	645.57B	719.18B	597.22B	334.33B	31.52B	15.52B	16.55B	1.25B	2.05B	3.47B	5.56B	4.66B	4.87B	5.49B	6.65B
Other Long-Term Liabilities	377.98B	179.93B	124.8B	188.35B	123.55B	1,110.5B	108.5B	374.92B	122.53B	132.72B	135.09B	249.59B	117.35B	69.33B	51.6B	58.46B	12.93B	166.93B	202.16B	97.47B	102.35B	106.06B	10.81B	9.55B
Total Long-Term Liabilities	5,521.7B	5,121.1B	5,348.8B	5,961.9B	5,917.7B	6,197.8B	1,351.5B	1,040.7B	955.67B	1,073.2B	1,225.8B	1,118.6B	753.43B	213.15B	230.05B	234.24B	98.03B	168.98B	205.64B	178.52B	184.09B	146.93B	134.1B	152.06B
Total Liabilities	7,834.8B	7,603.1B	7,494.5B	7,735.1B	8,093.6B	8,708.7B	2,089.1B	2,406.8B	1,812.9B	2,090B	2,028.5B	1,732.2B	1,505.2B	649.75B	658.53B	706.35B	526.75B	611.38B	693.87B	544.02B	554.65B	491.64B	505.88B	497.69B
Total Debt	4,843.8B	4,382.3B	4,345.4B	4,635.4B	5,093.3B	5,751B	985.66B	1,144.9B	768.22B	729.38B	859.98B	557.81B	562.56B	16.48B	18.8B	19.76B	5.83B	11.62B	12.59B	18.5B	14.64B	12.55B	11.94B	16.1B
Common Stock	1,676.6B	1,676.3B	1,676.3B	1,668.1B	1,668.1B	1,643.6B	168.65B	140.18B	133.59B	123.62B	103.43B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B	63.54B
Retained Earnings	1,391.2B	1,541.1B	1,479.7B	1,509.9B	1,370B	1,569.4B	1,557.3B	1,511.8B	1,523.1B	1,601.3B	1,901.3B	2,243.1B	2,254.1B	2,272.1B	2,166.3B	2,012.3B	2,523.6B	2,297.4B	2,062.2B	1,834.9B	1,616.7B	1,392.6B	1,175.9B	989.13B
Comprehensive Income	2,509.3B	1,508.1B	934.17B	366.11B	92.56B	349.88B	-4.79B	291B	327.94B	430.31B	466.63B	-185.51B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	7,273.3B	6,354.1B	5,683B	5,173B	4,723.5B	5,159.6B	1,997.4B	1,894.3B	1,948.7B	2,137B	2,470.7B	2,159.9B	2,012.3B	2,091.9B	2,121.3B	2,011.5B	2,280.8B	2,420.2B	2,348.4B	2,001.4B	1,781B	1,567.7B	1,420.1B	1,212.9B
Total Investments	445.7B	99.17B	96.58B	112.47B	107.33B	108.19B	385.03B	359.73B	268.16B	313.02B	387.79B	176.7B	186.7B	165.02B	197.84B	189.13B	292.78B	394.64B	387.96B	303.84B	356.59B	293.48B	406.74B	388.46B